Amatoxin-armed target-binding moieties for the treatment of cancer

Details for Australian Patent Application No. 2010234335 (hide)

Owner Deutsches Krebsforschungszentrum Faulstich, H.

Inventors Faulstich, Heinz; Breitling, Frank; Luttgau, Sandra; Moldenhauer, Gerhard

Agent Spruson & Ferguson

Pub. Number AU-A-2010234335

PCT Pub. Number WO2010/115630

Priority 61/167,690 08.04.09 US

Filing date 8 April 2010

Wipo publication date 14 October 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 October 2011 PCT application entered the National Phase

  PCT publication WO2010/115630 Priority application(s): WO2010/115630

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010234339-Drug delivery composition

2010234334-Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy